DE10342747A1 - Pharmazeutischer Wirkstoff gegen Melanome - Google Patents
Pharmazeutischer Wirkstoff gegen Melanome Download PDFInfo
- Publication number
- DE10342747A1 DE10342747A1 DE10342747A DE10342747A DE10342747A1 DE 10342747 A1 DE10342747 A1 DE 10342747A1 DE 10342747 A DE10342747 A DE 10342747A DE 10342747 A DE10342747 A DE 10342747A DE 10342747 A1 DE10342747 A1 DE 10342747A1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical agent
- agent against
- against melanomas
- melanomas
- vipers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Pharmazeutischer Wirkstoff zur Behandlung von Melanomen als Kombination von Substanzen, die aus biogenen Giften bzw. Mundsekreten bestimmter Arten von Vipern gewonnen werden.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10342747A DE10342747A1 (de) | 2003-09-16 | 2003-09-16 | Pharmazeutischer Wirkstoff gegen Melanome |
| DE112004002332T DE112004002332D2 (de) | 2003-09-16 | 2004-09-15 | Pharmazeutischer Wirkstoff aus Schlangengift gegen Melanome |
| PCT/DE2004/002058 WO2005027942A1 (de) | 2003-09-16 | 2004-09-15 | Pharmazeutischer wirkstoff aus schlangengift gegen melanome |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10342747A DE10342747A1 (de) | 2003-09-16 | 2003-09-16 | Pharmazeutischer Wirkstoff gegen Melanome |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE10342747A1 true DE10342747A1 (de) | 2005-04-28 |
Family
ID=34352861
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE10342747A Withdrawn DE10342747A1 (de) | 2003-09-16 | 2003-09-16 | Pharmazeutischer Wirkstoff gegen Melanome |
| DE112004002332T Expired - Fee Related DE112004002332D2 (de) | 2003-09-16 | 2004-09-15 | Pharmazeutischer Wirkstoff aus Schlangengift gegen Melanome |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE112004002332T Expired - Fee Related DE112004002332D2 (de) | 2003-09-16 | 2004-09-15 | Pharmazeutischer Wirkstoff aus Schlangengift gegen Melanome |
Country Status (2)
| Country | Link |
|---|---|
| DE (2) | DE10342747A1 (de) |
| WO (1) | WO2005027942A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1005321B (el) * | 2005-04-27 | 2006-10-09 | Χρηστος Καραμετας | Η φαρμακευτικη δραση αιθανολικου εκχυλισματος ζωικης προελευσης σε κακοηθη και μη κακοηθη νοσηματα |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5164196A (en) * | 1987-05-19 | 1992-11-17 | Ventech Research, Inc. | Crotoxin complex as cytotoxic agent |
| FR2623508B1 (fr) * | 1987-11-20 | 1990-04-20 | Commissariat Energie Atomique | Proteine basique denommee phospholipase a2 isolee de venin de serpent de la famille des elapides et sa sequence en amino-acides, derives et fragments de ladite proteine, leur procede d'obtention, compositions therapeutiques et agents de diagnostic contenant ladite proteine et/ou ses derives et/ou ses fragments |
| CN1098293A (zh) * | 1993-08-02 | 1995-02-08 | 程满温 | 蝎毒注射液及其制法和用法 |
| US5565431A (en) * | 1994-06-20 | 1996-10-15 | Lipps; Binie V. | Cancer cell inhibitors and method |
| CA2265631A1 (en) * | 1996-09-11 | 1998-03-19 | Elizabeth Shanahan-Prendergast | Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| CN1319612A (zh) * | 2000-01-28 | 2001-10-31 | 上海博道基因技术有限公司 | 一种新的多肽——人蝎子短链毒素蛋白9和编码这种多肽的多核苷酸 |
| CN1313099A (zh) * | 2000-03-10 | 2001-09-19 | 史洪雨 | 蜈蛇大膏药 |
| CN1352108A (zh) * | 2000-11-06 | 2002-06-05 | 上海博德基因开发有限公司 | 一种新的多肽——人蝎子短链毒素蛋白18.59和编码这种多肽的多核苷酸 |
| CN1424051A (zh) * | 2002-11-29 | 2003-06-18 | 包春杰 | 一种注射用蝎毒冻干粉针剂 |
-
2003
- 2003-09-16 DE DE10342747A patent/DE10342747A1/de not_active Withdrawn
-
2004
- 2004-09-15 WO PCT/DE2004/002058 patent/WO2005027942A1/de not_active Ceased
- 2004-09-15 DE DE112004002332T patent/DE112004002332D2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005027942A1 (de) | 2005-03-31 |
| DE112004002332D2 (de) | 2006-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| CY2014028I1 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
| ATE409176T1 (de) | 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen | |
| DE602004020072D1 (de) | 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen | |
| ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
| BRPI0411743A (pt) | método e composições para tratar doenças relacionadas a amilóides | |
| ATE430154T1 (de) | Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen | |
| TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| DE50013843D1 (de) | Arzneimittel zur behandlung von darmerkrankungen | |
| ATE422201T1 (de) | 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen | |
| WO2004073615A8 (en) | Deazaflavin compounds and methods of use thereof | |
| DE60308045D1 (de) | Pflanzenextrakte aus argyrolobium roseum zur behandlung von diabetes | |
| DE602006005640D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
| DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
| UA87291C2 (ru) | Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения | |
| DE10342747A1 (de) | Pharmazeutischer Wirkstoff gegen Melanome | |
| ATE457727T1 (de) | Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen | |
| DE602004029993D1 (de) | Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit | |
| DE602004010172D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen | |
| ATE545421T1 (de) | Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat | |
| SE0203817D0 (sv) | New composition | |
| ATE412411T1 (de) | Pmcol zur behandlung von prostatakrebs | |
| EP1484066A4 (de) | Mittel zur behandlung von infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8122 | Nonbinding interest in granting licences declared | ||
| 8143 | Withdrawn due to claiming internal priority |